Higher complete reperfusion rate seen with tenecteplase vs. alteplase in single-center study of stroke with LVO
Target: Stroke yields more frequent and faster thrombolysis, but disparities remain for non-white population
First-in-human trial demonstrates safety, encouraging functional response in chronic phases of recovery
AHA scientific statement offers best practices to improve care for high-risk populations
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Retrospective looks at a “direct to angio” MSU strategy and mechanical thrombectomy beyond 24 hours
Results from largest randomized trial of the technology to date
Subtle but important distinctions for ophthalmologists
New interventions and medications expand options, extend treatment window
Minority Stroke Program addresses racial disparities pinpointed in a recent study
Can TMS predict the potential functionality of impaired brains and steer patient treatment?